Myostatin Inhibitors Will Break Pharmaceutical Profit Records

By Patrick CoxPosted July 29, 2008

I'd like to tell you about a couple of important new breakthroughs that have just shown up on the radar. Both have enormous potential in terms of both your health and your portfolio.

You Must Be A Subscriber To View This Content.

If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication below and get access today!

Breakthrough Technology Alert

This is the best time to be investing in world-changing technologies, as unprecedented innovations are taking off right now… Breakthrough Technology Alert tirelessly researches these exciting new breakthrough technologies to keep you well informed, outline specific opportunities, and keep you ahead of the game.

Patrick Cox

Patrick Cox has lived deep inside transformative technologies for over 25 years. In the 1980s, he worked in software development and manufacturing. By the mid-‘90s, he consulted for Netscape–which handled 90% of all Internet browsing traffic at the time. InfoWorld and USA Today have featured his research, and he’s written for The Wall Street Journal,...

View More By Patrick Cox

2019 Looks Bright

By Ray BlancoPosted December 17, 2018

This year, the FDA made a record-breaking number of approvals on new drugs, many of which were for unique therapies. There are two companies bearing some of these groundbreaking therapies, and you don’t want to miss out…

A Hot Month for Our Portfolio

By Stephen PetranekPosted September 15, 2014

Some of our stocks have been performing extraordinarily well in the last few weeks. Or should I take that back? I will. Revise: Some of our stocks have been performing as we expected in the last few weeks, reflecting the values we have long expected. Last Thursday, I issued an alert on four of them and basically said to hold tight. But if you didn’t get into these stocks when we first bought them, and despite remarkable gains in just months, I don’t think any of them are overpriced. Each is likely to do at least as well in coming months as it has done so far.

A Letter From the Midwest

By Stephen PetranekPosted December 1, 2014

Thanksgiving greetings from Indianapolis, the home of a pharmaceutical firm that may be responsible for saving more lives than any other in history...

Stem Cell Leader’s Change of Plans May Signal that the Moment Has Arrived

By Patrick CoxPosted September 18, 2009

In my last regularly-scheduled alert, (cue music) I gave you the “heads up” about Dr. Michael West's next major speech this coming Wednesday at the 2009 World Stem Cell Summit meeting in Baltimore. Well, Dr. West won't be appearing in Baltimore, it's something much more exciting...

Good News for Tech Stocks in President’s State of the Union Speech

By Patrick CoxPosted February 2, 2010

The good news from the president's State of the Union speech is that he recognized that our federal deficit is a bad thing. His proposed spending freeze, starting next year, is only a symbolic gesture, but it is important. Here's how it affects breakthrough technologies...

Convergence on Schedule: What You Have to Know to Profit

By Patrick CoxPosted June 16, 2009

Dear Breakthrough Technology reader, This week, I’d like to discuss more about the financial implications of the “convergence.” More to the point, I’d like to tell you about the emergence of a few of the companies that will profit from this powerful technological trend. These are not unknown small caps, but are little known outside...